Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Greece

Research and Innovation Action · Running

AIRIS Mechanism-Informed Multimodal Generative AI for Causal and Dynamical Modelling in Biomedical Research

Coordinator
Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis Gnosis, Greece
Runs
1 June 2026 to 31 May 2030
Status
Running
EU funding
€16.9m
Total cost
€16.9m
Partners
22 organisations in 11 countries
Type
Research and Innovation Action
Grant agreement
101289094

What the project is doing

In the project's own words, from its summary on CORDIS.

AIRIS will develop the next generation of multimodal Generative AI (GenAI) models to accelerate research on predictive and personalised medicine. Building on recent advances in LLMs, causal inference and mechanistic modelling, AIRIS will integrate heterogeneous biomedical data (omics, imaging, clinical, laboratory, lifestyle, PROMs and scientific literature) into mechanism-informed generative frameworks. These models will not only generate biologically plausible synthetic data to address sparsity and bias but also embed causal and dynamical constraints across biological scales, from “virtual cells” to multi-organ models, enabling counterfactual reasoning and in-silico hypothesis testing.

The project will deliver (i) robust agentic multimodal data integration pipelines; (ii) novel mechanism-anchored generative architectures with interpretability and bias-mitigation safeguards; (iii) hypothesis generation assistants for biomarker discovery, drug repurposing, and intervention design; and (iv) a scalable MLOps infrastructure ensuring reproducibility. AIRIS will be validated using already existing large-scale datasets in five high-impact use cases including Pulmonary Fibrosis, Steatotic Liver Disease, Cardiovascular Disease, Chronic Kidney Disease and Inflammatory Bowel Disease.

AIRIS will demonstrate utility in modelling of disease, while also allowing cross-disease insights. A multidisciplinary consortium spanning leading universities and research centres, HPC experts, industry, and SME ensures excellence across the project dimensions. ELSI and fairness will be systematically addressed by SSH and legal experts. Outputs will be openly disseminated through benchmarks, training, and open-source releases, fostering European leadership in mechanism-informed GenAI.

AIRIS will maximise scientific, clinical, and societal impact by bridging AI innovation with biomedical discovery, improving disease understanding, and supporting equitable personalised care.

Topics

Who is involved

OrganisationCityCountryRole
Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis GnosisMaroussiGreeceCoordinator
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
TimelexBruxelles / BrusselBelgiumParticipant
The Research Institute of the Mcgill University Health CentreMontrealCanadaParticipant
Centre Hospitalier Universitaire VaudoisLausanneSwitzerlandParticipant
Universitaet BernBernSwitzerlandParticipant
Eurice European Research and Project Office GmbHSt IngbertGermanyParticipant
Forschungszentrum Julich GmbHJulichGermanyParticipant
Technische Universitaet MuenchenMuenchenGermanyParticipant
Universitaetsklinikum AachenAachenGermanyParticipant
A. Persidis & Sia OeAthinaGreeceParticipant
Charokopeio PanepistimioAthinaGreeceParticipant
Institut Catala De La SalutBarcelonaSpainParticipant
Alma Mater Studiorum - Universita Di BolognaBolognaItalyParticipant
Azienda Usl Della RomagnaRavennaItalyThird party
Elsevier BVAmsterdamNetherlandsParticipant
Universiteit Van AmsterdamAmsterdamNetherlandsParticipant
Linkopings UniversitetLinkopingSwedenParticipant
The University of ManchesterManchesterUnited KingdomParticipant
University College LondonLondonUnited KingdomParticipant
Mlcommons AssociationDoverUnited StatesParticipant
Yale UniversityNew HavenUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI